Last reviewed · How we verify
NCT06896682
Cortisol and Obesity - A Vicious Cycle? Hypoglycemia After Bariatric Surgery - Association With Cortisol Metabolism?
trial in Postbariatric Hypoglycemia in 100 participants. Currently enrolling.
31 December 2026
Quick facts
| Lead sponsor | Esbjerg Hospital - University Hospital of Southern Denmark |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 8 July 2025 |
| Primary completion | 31 December 2026 |
| Estimated completion | 31 December 2026 |
| Sites | 1 location across Denmark |
Conditions studied
- Postbariatric Hypoglycemia — all drugs for Postbariatric Hypoglycemia →
Sponsor
Esbjerg Hospital - University Hospital of Southern Denmark
Who can join
Eligibility, any sex, with Postbariatric Hypoglycemia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational study is to learn about how bariatric surgery affects the metabolism of cortisol. The main question it aims to answer is whether changes in cortisol contribute to the development of reactive hypoglycemia? 100 individuals who have previously undergone bariatric surgery, are planned to be included.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06896682
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Postbariatric Hypoglycemia
Currently open trials in the same condition.
- NCT07029412 — Study to Evaluate Efficacy and Dose Response of Imapextide (STEADI) · Phase 2 · recruiting
Other Esbjerg Hospital - University Hospital of Southern Denmark trials
Trials by the same sponsor.
- NCT07453186 — Transabdominal and Laparoscopic Ultrasound in a Bariatric Setting · NA · not yet recruiting
- NCT07454993 — The Effect of Music During Colonoscopy · NA · recruiting
- NCT06790225 — Glucose-dependent INsulinotropic Polypeptide: Effect on Bone Remodelling and Cell Activity (GINEBRA) · NA · recruiting
- NCT06619015 — Tailoring Obesity Treatment Trial · Phase 2, PHASE3 · withdrawn
- NCT06882993 — Feasibility of a Minimally Invasive Diagnostic Algorithm in Suspected Crohn's Disease · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06896682 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Esbjerg Hospital - University Hospital of Southern Denmark
- Last refreshed: 13 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06896682.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing